Silexion Therapeutics Raises $0.84M Through Warrant Inducement, Hires H.C. Wainwright as Agent

Silexion Therapeutics executed a warrant inducement to raise approximately $0.84 million in gross proceeds by reducing the exercise price of 3,216,928 existing Series E warrants to $0.2603 per share and agreeing to issue 6,433,856 new warrants (Series F and G) at the same price. The new warrants wi…